102-PA01S
antibody from ReliaTech GmbH
Targeting: PGF
D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 102-PA01S - Provider product page
- Provider
- ReliaTech GmbH
- Product name
- PlGF (Peptide)
- Antibody type
- Polyclonal
- Antigen
- N-terminal peptide (20aa) of native human PlGF
- Description
- antibody Protein-A purified from serum
- Reactivity
- Human
- Host
- Rabbit
- Antibody clone number
- Rabbit IG
- Vial size
- 100 µl
- Storage
- Store lyophilized at 2-8°C for 6 months or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing.
- Handling
- Restore in sterile water to a concentration of 0.1-1.0 mg/ml. The antibody solution should be gently mixed before use.
Submitted references Proteolytic Processing Regulates Placental Growth Factor Activities
Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Hoffmann D, Willenborg S, Koch M, Zwolanek D, Müller S, Becker A, Metzger S, Ehrbar M, Kurschat P, Hellmich M, Hubbell J, Eming S
Journal of Biological Chemistry 2013 June;288(25):17976-17989
Journal of Biological Chemistry 2013 June;288(25):17976-17989
Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate K, Machein M
Cancer Research 2008 September;68(18):7342-7351
Cancer Research 2008 September;68(18):7342-7351
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate K, Foidart J, Schaper W, Charnock-Jones D, Hicklin D, Herbert J, Collen D, Persico M
Nature Medicine 2001 May;7(5):575-583
Nature Medicine 2001 May;7(5):575-583
No comments: Submit comment
Supportive validation
- Submitted by
- ReliaTech GmbH (provider)
- Main image
- Experimental details
- Western analysis of human PlGF-2 with a polyclonal antibody directed against a N-terminal peptide of native human PlGF. There is a strong cross reactivity with mouse PlGF.
- Sample type
- Purified recombinant proteins
- Submitted by
- ReliaTech GmbH (provider)
- Main image
- Experimental details
- Western analysis of human PlGF isoforms with a polyclonal antibody directed against a N-terminal peptide of native human PlGF. There is a weak cross reactivity with rat PlGF.
- Sample type
- Sf9 conditioned media